Skip to content

Evaluation of the efficacy of partial Müllerectomy in the fat degenerated area following levator advancement in the correction of mild to moderate ptosis

Evaluation of the efficacy of partial Müllerectomy in the fat degenerated area following levator advancement in the correction of mild to moderate ptosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077221
Enrollment
Unknown
Registered
2023-11-01
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blepharoptosis

Interventions

Test group:Perform the partial Müllerectomy in the fat degenerated area following levator advancement through small incision

Sponsors

Southeast University Affiliated Zhongda Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: ?Patients with a preoperative diagnosis of mild to moderate ptosis (upper lid margin obscuring the cornea >2mm and =6mm) and levator muscle strength =5mm and <10mm; ?Intraoperative observation of a yellow mass of fatty deposits in the Müller's muscle (with or without the levator muscle and levator aponeurosis); ?Retain patients who fulfil the first 2 criteria but who undergo correction of the medial canthus with a modified Z-shaped canthus simultaneously; ?Retain patients who fulfil the first two criteria but with thinned or severed levator aponeurosis intraoperatively.

Exclusion criteria

Exclusion criteria: ?Patients with severe ptosis on one or both sides and unilateral ptosis; ?Patients with severe ptosis with one or both levator muscle strength less than 5mm; ?Patients with ptosis due to neurogenic, pseudo, mechanical, or progressive extraocular muscle paralysis; ?Patients with obvious laxity of the upper eyelid skin; ?Patients with strabismus, diseases of extraocular muscles and appendages; ?Patients with a history of previous upper eyelid surgery; ?Pregnant and breastfeeding women; ?Patients with infection, eczema, herpes, abscess, cellulitis, ringworm and burns on the upper eyelid area; ?Those who are allergic to drugs(iodophor, alcohol, gentian violet, lidocaine, etc.) used intraoperatively; ?Patients with severe comorbidities, mental illnesses and coagulation disorders found before or during surgery; ?Patients with incomplete information and missed visits.

Design outcomes

Primary

MeasureTime frame
Margin reflection distance1(MRD1);Vertical eyelid fissure height(VEFH);Levator function(LF);

Secondary

MeasureTime frame
Bleeding, oedema, bruising, pain, eye discomfort within 1 week;Scar;Bilateral upper eyelid contour and symmetry;Doctor and patient satisfaction;

Countries

China

Contacts

Public ContactFangfang Guo

Southeast University Affiliated Zhongda Hospital

anyeguofangfang@163.com+86 138 5181 8962

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026